Caribou Biosciences, Inc.
CRBU- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001619856
No open-market purchases or sales by Caribou Biosciences, Inc. insiders were filed in the last 90 days; 137 institutions reported holding it in 13F filings for Q2 2026, worth $84.8M in total; Maverick Capital is the only superinvestor holding it.
Superinvestors holding CRBU, Q2 2026
1 superinvestor reports holding Caribou Biosciences, Inc. on Form 13F, worth $1.15M in total. Weight is Caribou Biosciences, Inc.'s share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Maverick CapitalLee Ainslie | <0.1% | 652,542 | $1.15M | Unchanged |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of CRBU each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q4 2022
1 superinvestor holding at quarter end
- Sold out
- Duquesne Family Office
Q1 2022
2 superinvestors holding at quarter end
- Sold out
- Coatue Management
Q4 2021
3 superinvestors holding at quarter end
- Reduced
- Maverick Capital (−31.5%), Coatue Management (−20.3%)
- Sold out
- ARK Invest
Q3 2021
4 superinvestors holding at quarter end